HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antipoliomyelitis immunity status among a population that was regularly vaccinated 11-12 years before.

Abstract
A study of poliomyelitis neutralizing antibodies was carried out on 165 samples of blood serum drawn from subjects aged 14-15 years who had completed vaccination with OPV 11 or 12 years ago. Two different methods of incubation of the serum-virus mixtures (1 hour at 37 degrees C; 6 hours at 37 degrees C and then 18 hours at 4 degrees C, respectively) and two different cell lines (RC-37 and Hep-2) for the inoculation of these mixtures were employed. The results were also evaluated in relation to different initial dilutions of the sera (from 1:4 to 1:1). With the 1:4 initial serum dilution the highest frequencies of sero-negativity were observed utilizing the short incubation time and inoculation in Hep-2 (42% for polio 1, 10% for polio 2, 32% for polio 3). These frequencies diminish significantly utilizing the RC-37 cell line and the long incubation respectively. Under all the experimental conditions the results were better when the 1:2 initial serum dilutions were employed and even better when undiluted sera were used. Neutralizing antibodies against the 3 types of poliovirus were detected in the undiluted sera of all the subjects utilizing the long incubation and inoculation in either the RC-37 or the Hep-2 cell lines. In three subjects lacking detectable antibodies at the 1:4 dilution of the sera, the administration of a dose of IPV produced after 5-7 days a high response which remained almost unchanged 30 days later.
AuthorsE Bellelli, M L Tanzi, V Bocelli, U Bracchi, P Affanni
JournalEuropean journal of epidemiology (Eur J Epidemiol) Vol. 7 Issue 6 Pg. 605-11 (Nov 1991) ISSN: 0393-2990 [Print] Netherlands
PMID1664344 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
  • Poliovirus Vaccine, Oral
Topics
  • Adolescent
  • Antibodies, Viral (biosynthesis)
  • Cell Line
  • Humans
  • Immunity
  • Italy (epidemiology)
  • Neutralization Tests
  • Poliomyelitis (epidemiology, immunology, prevention & control)
  • Poliovirus (immunology)
  • Poliovirus Vaccine, Oral (immunology)
  • Seroepidemiologic Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: